Dr. Hella Bolck

Work at ZHAW

Position

• Third Space Scientist
• Research- and Project Manager

Focus

• Managing complex projects
• Enabling research in the academic third space
• Using AI for analysis of biological and medical images and data

Experience

• Senior Research Scientist
  University Hospital Zürich
  05 / 2018 - 01 / 2024
• Postdoctoral Scientist
  University Hospital Zürich
  04 / 2016 - 04 / 2018
• Doctoral Researcher
  University of Zürich
  09 / 2011 - 04 / 2016

Education and Continuing education

Education

• PhD / Cancer Biology
  University of Zürich
  09 / 2011 - 04 / 2016
• Master / Biochemistry and Molecular Biology
  Friedrich-Schiller University Jena
  10 / 2005 - 08 / 2011

Network

Social media

LinkedIn

Projects

• AI4REALNET: AI for REAL-world NETwork operation / Team member / Project ongoing
• LINA: Shared Large-scale Infrastructure for the Development and Safe Testing of Autonomous Systems / Deputy project leader / Project ongoing

Publications before appointment at the ZHAW

• SuperCUT, an unsupervised multimodal image registration with deep learning for biomedical microscopy. Brief. Bioinformatics (2024)
• Genomic alterations and diagnosis of renal cancer. Virchows Archiv (Nov. 2023)
• Ex vivo drug testing of patient‐derived papillary renal cancer cells reveals EGFR and the BCL2 family as therapeutic targets. Eur Urol Focus (Mar. 2023)
• RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor. Cells (Feb. 2022)
• SF3B1 facilitates HIF1‐signaling and promotes malignancy in pancreatic cancer. Cell Rep (Aug. 2022)
• Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease. Front Oncol (Oct. 2020)
• Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision Medicine. Front Cell Dev Biol (Oct. 2019)
• Tracing Clonal Dynamics Reveals that Two‐ and Three‐dimensional Patient‐derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma. Eur Urol Focus (Jun. 2019)
• Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear‐cell renal cell carcinoma. J Lipid Res (Nov. 2018)
• CtIP‐Mediated Fork Protection Synergizes with BRCA1 to Suppress Genomic Instability upon DNA Replication Stress. Mol Cell (Oct. 2018)
• FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep (May 2014)
• Targeting DNA double‐strand break signalling and repair: recent advances in cancer therapy. Swiss Med Wkly (Jul. 2013)
• Breakdown of the FLT3‐ITD/STAT5 axis and synergistic apoptosis induction by the histone deacetylase inhibitor panobinostat and FLT3‐ specific inhibitors. Mol Cancer Ther (Sept 2012)

go back